nodes	percent_of_prediction	percent_of_DWPC	metapath
Isopropamide—CHRM4—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0444	0.0457	CbGpPWpGaD
Isopropamide—CHRM4—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0379	0.039	CbGpPWpGaD
Isopropamide—CHRM4—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0368	0.0379	CbGpPWpGaD
Isopropamide—CHRM4—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0342	0.0353	CbGpPWpGaD
Isopropamide—CHRM4—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0318	0.0328	CbGpPWpGaD
Isopropamide—CHRM4—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0309	0.0318	CbGpPWpGaD
Isopropamide—CHRM1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0299	0.0308	CbGpPWpGaD
Isopropamide—CHRM3—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0298	0.0307	CbGpPWpGaD
Isopropamide—CHRM4—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0288	0.0296	CbGpPWpGaD
Isopropamide—CHRM1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0255	0.0263	CbGpPWpGaD
Isopropamide—CHRM3—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0254	0.0262	CbGpPWpGaD
Isopropamide—CHRM1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0248	0.0255	CbGpPWpGaD
Isopropamide—CHRM3—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0247	0.0254	CbGpPWpGaD
Isopropamide—CHRM4—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.024	0.0247	CbGpPWpGaD
Isopropamide—CHRM1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0231	0.0238	CbGpPWpGaD
Isopropamide—CHRM3—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.023	0.0237	CbGpPWpGaD
Isopropamide—CHRM1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0215	0.0221	CbGpPWpGaD
Isopropamide—CHRM3—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0214	0.022	CbGpPWpGaD
Isopropamide—CHRM1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0208	0.0215	CbGpPWpGaD
Isopropamide—CHRM3—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0208	0.0214	CbGpPWpGaD
Isopropamide—CHRM4—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0202	0.0208	CbGpPWpGaD
Isopropamide—CHRM1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0194	0.02	CbGpPWpGaD
Isopropamide—CHRM3—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0193	0.0199	CbGpPWpGaD
Isopropamide—CHRM1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0162	0.0167	CbGpPWpGaD
Isopropamide—CHRM3—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0161	0.0166	CbGpPWpGaD
Isopropamide—Modafinil—SLC6A3—Gilles de la Tourette syndrome	0.0157	0.536	CrCbGaD
Isopropamide—Benzphetamine—SLC6A3—Gilles de la Tourette syndrome	0.0136	0.464	CrCbGaD
Isopropamide—CHRM1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0136	0.014	CbGpPWpGaD
Isopropamide—CHRM3—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0135	0.014	CbGpPWpGaD
Isopropamide—CHRM3—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.0113	0.0116	CbGpPWpGaD
Isopropamide—CHRM3—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.011	0.0113	CbGpPWpGaD
Isopropamide—CHRM4—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00787	0.00811	CbGpPWpGaD
Isopropamide—CHRM4—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00764	0.00787	CbGpPWpGaD
Isopropamide—CHRM4—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00731	0.00753	CbGpPWpGaD
Isopropamide—CHRM3—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00716	0.00738	CbGpPWpGaD
Isopropamide—CHRM4—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00712	0.00733	CbGpPWpGaD
Isopropamide—CHRM4—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00709	0.00731	CbGpPWpGaD
Isopropamide—CHRM4—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00661	0.00681	CbGpPWpGaD
Isopropamide—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00626	0.00645	CbGpPWpGaD
Isopropamide—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00608	0.00626	CbGpPWpGaD
Isopropamide—CHRM1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00602	0.0062	CbGpPWpGaD
Isopropamide—CHRM1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00584	0.00602	CbGpPWpGaD
Isopropamide—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00566	0.00583	CbGpPWpGaD
Isopropamide—CHRM1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00544	0.0056	CbGpPWpGaD
Isopropamide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00493	0.00508	CbGpPWpGaD
Isopropamide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00491	0.00506	CbGpPWpGaD
Isopropamide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00478	0.00493	CbGpPWpGaD
Isopropamide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00477	0.00491	CbGpPWpGaD
Isopropamide—CHRM4—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00477	0.00491	CbGpPWpGaD
Isopropamide—CHRM4—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00463	0.00477	CbGpPWpGaD
Isopropamide—CHRM4—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00463	0.00477	CbGpPWpGaD
Isopropamide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00445	0.00459	CbGpPWpGaD
Isopropamide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00444	0.00458	CbGpPWpGaD
Isopropamide—CHRM4—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00431	0.00444	CbGpPWpGaD
Isopropamide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00422	0.00435	CbGpPWpGaD
Isopropamide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00421	0.00433	CbGpPWpGaD
Isopropamide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0041	0.00422	CbGpPWpGaD
Isopropamide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00408	0.00421	CbGpPWpGaD
Isopropamide—CHRM1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00404	0.00416	CbGpPWpGaD
Isopropamide—CHRM3—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00402	0.00415	CbGpPWpGaD
Isopropamide—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00396	0.00408	CbGpPWpGaD
Isopropamide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00382	0.00393	CbGpPWpGaD
Isopropamide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.0038	0.00392	CbGpPWpGaD
Isopropamide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00361	0.00372	CbGpPWpGaD
Isopropamide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.0036	0.00371	CbGpPWpGaD
Isopropamide—CHRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00321	0.00331	CbGpPWpGaD
Isopropamide—CHRM3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.0032	0.0033	CbGpPWpGaD
Isopropamide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00312	0.00321	CbGpPWpGaD
Isopropamide—CHRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00312	0.00321	CbGpPWpGaD
Isopropamide—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00311	0.0032	CbGpPWpGaD
Isopropamide—CHRM3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00311	0.0032	CbGpPWpGaD
Isopropamide—CHRM3—Metabolism—HDC—Gilles de la Tourette syndrome	0.00307	0.00316	CbGpPWpGaD
Isopropamide—CHRM4—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00302	0.00311	CbGpPWpGaD
Isopropamide—CHRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00291	0.00299	CbGpPWpGaD
Isopropamide—CHRM3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.0029	0.00298	CbGpPWpGaD
Isopropamide—CHRM4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00269	0.00278	CbGpPWpGaD
Isopropamide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00267	0.00275	CbGpPWpGaD
Isopropamide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00266	0.00275	CbGpPWpGaD
Isopropamide—CHRM4—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00261	0.00269	CbGpPWpGaD
Isopropamide—CHRM4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00245	0.00252	CbGpPWpGaD
Isopropamide—CHRM4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00244	0.00251	CbGpPWpGaD
Isopropamide—CHRM4—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00237	0.00245	CbGpPWpGaD
Isopropamide—CHRM4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00221	0.00228	CbGpPWpGaD
Isopropamide—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00204	0.0021	CbGpPWpGaD
Isopropamide—CHRM3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00203	0.00209	CbGpPWpGaD
Isopropamide—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00182	0.00187	CbGpPWpGaD
Isopropamide—CHRM3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00181	0.00187	CbGpPWpGaD
Isopropamide—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00176	0.00182	CbGpPWpGaD
Isopropamide—CHRM3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00176	0.00181	CbGpPWpGaD
Isopropamide—CHRM4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00171	0.00176	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00165	0.0017	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00164	0.00169	CbGpPWpGaD
Isopropamide—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00164	0.00169	CbGpPWpGaD
Isopropamide—CHRM3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00164	0.00169	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.0016	0.00165	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.0016	0.00164	CbGpPWpGaD
Isopropamide—CHRM4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00155	0.0016	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00149	0.00154	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00149	0.00153	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00144	0.00149	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.0014	0.00145	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00131	0.00135	CbGpPWpGaD
Isopropamide—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00115	0.00119	CbGpPWpGaD
Isopropamide—CHRM3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00115	0.00118	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00104	0.00108	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00104	0.00107	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000974	0.001	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000971	0.001	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000946	0.000974	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000943	0.000971	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000915	0.000943	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000881	0.000908	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000878	0.000905	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000617	0.000636	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000615	0.000634	CbGpPWpGaD
